| Benzbromarone in the treatment of gout VF Azevedo, IA Kos, AB Vargas-Santos, GRC Pinheiro, ES Paiva Advances in Rheumatology 59, 37, 2019 | 103 | 2019 |
| IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination L Thurner, C Kessel, N Fadle, E Regitz, F Seidel, I Kindermann, S Lohse, ... New England Journal of Medicine 387 (16), 1524-1527, 2022 | 61 | 2022 |
| Prolonged course of COVID-19-associated pneumonia in a B-cell depleted patient after rituximab I Kos, B Balensiefer, S Roth, M Ahlgrimm, M Sester, T Schmidt, L Thurner, ... Frontiers in Oncology 10, 1578, 2020 | 57 | 2020 |
| Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study J Pfeifer, B Thurner, C Kessel, N Fadle, P Kheiroddin, E Regitz, ... The Lancet Rheumatology 4 (5), e329-e337, 2022 | 55 | 2022 |
| The biosimilars journey: current status and ongoing challenges IA Kos, VF Azevedo, DE Neto, SC Kowalski Drugs in context 7, 2018 | 32 | 2018 |
| Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market MA Scheinberg, PAO Felix, IA Kos, MDA Andrade, VF Azevedo Einstein (São Paulo) 16, eRW4175, 2018 | 18 | 2018 |
| Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients I Kos, B Balensiefer, V Lesan, D Kaddu‐Mulindwa, L Thurner, ... European journal of immunology 51 (6), 1449-1460, 2021 | 15 | 2021 |
| Autoantibodies against Progranulin and IL-1 receptor antagonist in critically ill COVID-19 L Thurner, N Fadle, M Bewarder, I Kos, E Regitz, O Cetin, B Thurner, ... | 13* | 2021 |
| Management of extranodal marginal zone lymphoma: present and upcoming perspectives D Kaddu-Mulindwa, L Thurner, K Christofyllakis, M Bewarder, IA Kos Cancers 14 (12), 3019, 2022 | 10 | 2022 |
| The experience with biosimilars of infliximab in rheumatic diseases VF Azevedo, IA Kos, L Ariello Current Pharmaceutical Design 23 (44), 6752-6758, 2017 | 9 | 2017 |
| B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma L Thurner, N Fadle, E Regitz, S Roth, O Cetin, IA Kos, SM Hess, J Bein, ... Haematologica 108 (12), 3347, 2023 | 8 | 2023 |
| Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019 V Lesan, M Bewarder, C Metz, A Becker, S Mang, E Regitz, L Thurner, ... Intensive Care Medicine Experimental 9, 1-10, 2021 | 8 | 2021 |
| New monoclonal antibody biosimilars approved in 2015 in Latin America: position statement of the Latin American Forum on Biosimilars in biosimilarity, interchangeability and … V Feijó Azevedo, A Babini, F Vieira Teixeira, I Age Kos, P Matar Pro Pharma Communications International, 2016 | 8 | 2016 |
| Parceria para o desenvolvimento produtivo com produtos biossimilares: perspectivas de acesso a produtos biológicos no mercado brasileiro MA Scheinberg, PAO Felix, IA Kos, MDA Andrade, VF Azevedo Einstein (São Paulo) 16, eRW4175, 2018 | 7 | 2018 |
| Consenso brasileiro multi-institucional de pacientes sobre medicamentos biossimilares P Torres, I Kos, A Isaac, N Oliveira, MI da Silva, A Oliveira, S Caetano, ... JBES-Jornal Brasileiro de Economia da Saúde 9 (1), 39-43, 2017 | 7 | 2017 |
| Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature I Kos, S Stilgenbauer, M Bewarder Clinical Research in Cardiology 109 (11), 1438-1441, 2020 | 6 | 2020 |
| Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report K Christofyllakis, AR Monteiro, O Cetin, IA Kos, A Greystoke, A Luciani Journal of Geriatric Oncology 13 (8), 1071-1083, 2022 | 5 | 2022 |
| Autoantibodies against SUMO1-DHX35 in long-COVID L Thurner, N Fadle, E Regitz, KD Preuss, F Neumann, O Cetin, ... Journal of Translational Autoimmunity 5, 100171, 2022 | 5 | 2022 |
| Benzbromarone in the treatment of gout. Adv Rheumatol 59: 37 VF Azevedo, IA Kos, AB Vargas-Santos, G da Rocha Castelar Pinheiro, ... | 5 | 2019 |
| Advances in lymphoma molecular diagnostics IA Kos, L Thurner, JT Bittenbring, K Christofyllakis, D Kaddu-Mulindwa Diagnostics 11 (12), 2174, 2021 | 4 | 2021 |
